Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Journal of Clinical Pharmacology|May 16, 2018
Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-Cell TransplantationAkira Okada, Misato Kariya, Kei Irie, et al.Internal Medicine (Tokyo, Japan)|March 2, 2010
Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosisSumie Tabata, Minako Mori, Yuya Nagai, et al.International Journal of Hematology|August 21, 2009
Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosisSumie Tabata, Sonoko Shimoji, Kimihiko Murase, et al.American Journal of Hematology|November 11, 2014
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphomaShinichi Kako, Koji Izutsu, Koji Kato, et al.Respiratory Care|March 11, 2025
Increased Oxygen Consumption Ability With Pulmonary Rehabilitation Improves Submaximal Exercise Capacity in Advanced COPDHitoshi Sumitani, Keisuke Miki, Yukio Yamamoto, et al.Respiratory Investigation|September 21, 2024
Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasisSatoshi Miyamoto, Keisuke Miki, Seigo Kitada, et al.BMC Pulmonary Medicine|November 1, 2024
Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary diseaseHiromi Yanagi, Keisuke Miki, Kazumi Koyama, et al.Annals of Hematology|July 27, 2018
Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphomaSatoshi Yamasaki, Dai Chihara, Sung-Won Kim, et al.Annals of Hematology|April 4, 2018
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphomaSatoshi Yamasaki, Dai Chihara, Sung-Won Kim, et al.Journal of Hematology & Oncology|September 5, 2015
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancyYasuyuki Arai, Kazunari Aoki, June Takeda, et al.Pageof 7